As of 2026-10-14, the Relative Valuation of Nuvation Bio Inc (NUVB) is (10.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.72 USD, the upside of Nuvation Bio Inc based on Relative Valuation is -320.6%.
The range of the Relative Valuation is (8.13) - (9.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 33.8x | 28.5x |
| Forward P/E multiples | 16.2x - 21.4x | 19.9x |
| Fair Price | (8.13) - (9.21) | (10.41) |
| Upside | -272.3% - -295.1% | -320.6% |
| Date | P/E |
| 2026-10-13 | -11.35 |
| 2026-10-12 | -11.39 |
| 2026-10-09 | -11.62 |
| 2026-10-08 | -11.50 |
| 2026-10-07 | -11.29 |
| 2026-10-06 | -11.34 |
| 2026-10-05 | -11.50 |
| 2026-10-02 | -11.95 |
| 2026-10-01 | -12.92 |
| 2026-09-30 | -13.01 |
| 2026-09-29 | -13.06 |
| 2026-09-28 | -13.01 |
| 2026-09-25 | -13.34 |
| 2026-09-24 | -13.32 |
| 2026-09-23 | -13.27 |
| 2026-09-22 | -14.18 |
| 2026-09-21 | -14.11 |
| 2026-09-18 | -13.60 |
| 2026-09-17 | -14.11 |
| 2026-09-16 | -13.43 |
| 2026-09-15 | -13.48 |
| 2026-09-14 | -13.80 |
| 2026-09-11 | -14.11 |
| 2026-09-10 | -14.59 |
| 2026-09-09 | -15.15 |
| 2026-09-08 | -15.36 |
| 2026-09-04 | -15.83 |
| 2026-09-03 | -15.73 |
| 2026-09-02 | -16.11 |
| 2026-09-01 | -15.43 |
| 2026-08-31 | -15.48 |
| 2026-08-28 | -15.48 |
| 2026-08-27 | -16.24 |
| 2026-08-26 | -16.18 |
| 2026-08-25 | -16.50 |
| 2026-08-24 | -15.71 |
| 2026-08-21 | -16.11 |
| 2026-08-20 | -15.87 |
| 2026-08-19 | -16.87 |
| 2026-08-18 | -16.18 |
| 2026-08-17 | -15.06 |
| 2026-08-14 | -14.46 |
| 2026-08-13 | -14.18 |
| 2026-08-12 | -14.92 |
| 2026-08-11 | -14.80 |
| 2026-08-10 | -15.34 |
| 2026-08-07 | -15.34 |
| 2026-08-06 | -14.20 |
| 2026-08-05 | -14.80 |
| 2026-08-04 | -14.97 |